Loading...
Align Technology, Inc.
ALGN•NASDAQ
Healthcare
Medical - Devices
$207.19
$1.63(0.79%)
Align Technology, Inc. (ALGN) Financial Performance & Income Statement Overview
Review Align Technology, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
3.54%
↑ 3.54%
Operating Income Growth
-5.55%
↓ 5.55%
Net Income Growth
-5.32%
↓ 5.32%
Operating Cash Flow Growth
-6.05%
↓ 6.05%
Operating Margin
14.69%
↑ 14.69%
Gross Margin
69.87%
↑ 69.87%
Net Profit Margin
10.29%
↑ 10.29%
ROE
10.67%
↑ 10.67%
ROIC
14.22%
↑ 14.22%
Align Technology, Inc. (ALGN) Income Statement & Financial Overview
Review Align Technology, Inc.'s (ALGN) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $979.26M | $995.22M | $977.87M | $1.03B |
| Cost of Revenue | $299.15M | $309.24M | $296.10M | $305.86M |
| Gross Profit | $680.11M | $696.94M | $681.77M | $722.63M |
| Gross Profit Ratio | $0.69 | $0.70 | $0.70 | $0.70 |
| R&D Expenses | $97.20M | $94.88M | $85.27M | $92.19M |
| SG&A Expenses | $447.63M | $424.97M | $434.14M | $452.26M |
| Operating Expenses | $549.008M | $552.79M | $519.41M | $549.97M |
| Total Costs & Expenses | $848.16M | $851.07M | $815.57M | $881.44M |
| Interest Income | $5.32M | $8.52M | $4.003M | $3.30M |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $39.15M | $38.13M | $37.79M | $36.17M |
| EBITDA | $174.43M | $215.22M | $200.16M | $214.34M |
| EBITDA Ratio | $0.18 | $0.22 | $0.20 | $0.21 |
| Operating Income | $131.10M | $144.15M | $162.30M | $147.05M |
| Operating Income Ratio | $0.13 | $0.14 | $0.17 | $0.14 |
| Other Income/Expenses (Net) | $9.34M | -$3.37M | $3.63M | -$3.18M |
| Income Before Tax | $140.44M | $140.78M | $165.93M | $143.87M |
| Income Before Tax Ratio | $0.14 | $0.14 | $0.17 | $0.14 |
| Income Tax Expense | $47.21M | $36.97M | $49.97M | $47.30M |
| Net Income | $93.23M | $103.81M | $115.96M | $96.56M |
| Net Income Ratio | $0.10 | $0.10 | $0.12 | $0.09 |
| EPS | $1.27 | $1.39 | $1.55 | $1.28 |
| Diluted EPS | $1.27 | $1.39 | $1.55 | $1.28 |
| Weighted Avg Shares Outstanding | $73.56M | $74.42M | $74.74M | $75.18M |
| Weighted Avg Shares Outstanding (Diluted) | $73.61M | $74.47M | $74.76M | $75.22M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan